tiprankstipranks
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market
CNTX
Context Therapeutics
RESEARCH TOOLSreports
Want to see CNTX full AI Analyst Report?

Context Therapeutics (CNTX) Income Statement

242 Followers

Context Therapeutics Income Statement

Last quarter (Q1 2026), Context Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Context Therapeutics's net income was $-8.68M. See Context Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 39.70M$ 29.92M$ 25.07M$ 15.38M$ 10.53M
Depreciation and Amortization
$ 16.25K$ 10.88K$ 12.04K$ 9.27K$ 0.00
EBITDA
$ -39.69M$ -29.91M$ -25.06M$ -14.87M$ -10.39M
Operating Income
$ -39.70M$ -29.92M$ -25.07M$ -15.38M$ -10.53M
Other Income/Expenses
$ 3.58M$ 3.20M$ 1.11M$ 545.26K$ 68.95K
Pretax Income
$ -36.12M$ -26.73M$ -23.96M$ -14.84M$ -10.46M
Net Income
$ -36.12M$ -26.73M$ -23.96M$ -14.84M$ -10.46M
Per Share Metrics
Basic EPS
$ -0.38$ -0.46$ -1.50$ -0.93$ -3.69
Diluted EPS
$ -0.38$ -0.46$ -1.50$ -0.93$ -3.69
Weighted Average Shares Outstanding
 95.19M 58.42M 15.97M 15.97M 2.83M
Weighted Average Shares Outstanding (Diluted)
 95.19M 58.42M 15.97M 15.97M 2.83M
Currency in USD

Context Therapeutics Earnings and Revenue History